Crossmark

Rhynchophylline alleviates cognitive deficits in multiple transgenic mouse models of Alzheimer’s disease via modulating neuropathology and gut microbiota

Crossref DOI link: https://doi.org/10.1038/s41401-025-01475-0

Published Online: 2025-02-26

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhong, Mei

Xu, Qing-qing

Huang, Ming-qing

Zhan, Ruo-ting

Huang, Xiao-qi

Yang, Wen

Lin, Zhi-xiu

Xian, Yan-fang
License Information

Text and Data Mining valid from 2025-02-26

Version of Record valid from 2025-02-26
More Information

Article History

Received: 31 October 2024

Accepted: 2 January 2025

First Online: 26 February 2025

Competing interests

: The authors declare no competing interests.

: All experimental procedures were approved by the Animal Experimentation Ethics Committee of CUHK (Ref. No.: 21/067/NSF).

: All authors have consented for publication.

Document is current

Any future updates will be listed below